Gain Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q1 2020 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Gain Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2020 to Q1 2024.
- Gain Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $3.02M, a 43.3% increase year-over-year.
- Gain Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $10.2M.
- Gain Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$14.8M, a 15583% decline from 2021.
- Gain Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$94.2K, a 352% decline from 2020.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)